addressalign-toparrow-leftarrow-rightbackbellblockcalendarcameraccwchatcheckchevron-downchevron-leftchevron-rightchevron-small-downchevron-small-leftchevron-small-rightchevron-small-upchevron-upcircle-with-checkcircle-with-crosscircle-with-pluscrossdots-three-verticaleditemptyheartexporteye-with-lineeyefacebookfolderfullheartglobegmailgoogleimageimagesinstagramlinklocation-pinmagnifying-glassmailminusmoremuplabelShape 3 + Rectangle 1outlookpersonplusprice-ribbonImported LayersImported LayersImported Layersshieldstartickettrashtriangle-downtriangle-uptwitteruseryahoo

Frontiers in Drug Discovery and Development: Pre-clinial

NOTE: Get your ticket on Eventbrite at .

Drug discovery and development remains a stalwart of solutions to health issues and we’re presenting an extensive series on the topic. In the first event of this series, you have the chance to interact simultaneously with a CEO, CSO, VP of R&D and Sr. Principal Scientist of some outstanding organizations.

Drs. Andy Blight (Chief Scientific Officer at Acorda Therapeutics), Peter Ihnat (Senior Principal Scientist at Bristol-Myers Squibb), Stephen Chang (Vice President for Research and Development at The New York Stem Cell Foundation) and Yuval cohen (CEO at JB Therapeutics) will provide their perspectives on where the field of therapeutics is going, its current trends and landscape.

We’ll learn from their experience, success and failures, as they provide insight into the process and what it takes for a candidate to make it through pre-clinical stages. Panelists will also provide invaluable advice to biotech community on carriers available in this field.

At the end of the panel discussion, we'll take questions and have time for networking. Refreshments will be served.

Special thanks for NYU Bio Tech club for sponsoring the event. For questions regarding the event please email Keren Weiser at [masked] .

Join or login to comment.

  • Mary J A.

    Excellent speakers brought up key points. John did an amazing job as host and circling round with panel and questions.

    September 27, 2013

  • Stefan

    Excellent lineup of speakers!

    1 · September 27, 2013

  • douglas B.

    The clinical trial process lengthy and the resources for companies are vastly different. Why can't there be standardized process, when applicable, with the FDA? It would be prudent to take lessons learned, both positive and negative and streamline the clinical trial process. It is crucial to get drugs to commercialization, when warranted, and the current process is not working effectively.

    September 23, 2013

People in this
Meetup are also in:

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy